PolyPid Ltd.
PYPDNasdaq
$5.37
↑ +3.5%Jul 17 close · end-of-day
Price
1Y↑ +42.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$87.8M
Enterprise Value
$76.9M
P/E
2.6
P/S
—
P/B
4.3
EV/EBITDA
—
PEG
—
FCF Yield
-32.0%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$34.2M
Free Cash Flow (TTM)
-$28.1M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-166.9%
ROIC
-272.0%
Debt / Equity
0.3
Net Cash
$10.9M
Return 1Y
+41.3%
Company profile
PolyPid Ltd. develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs)
- CEO
- Dikla C. Akselbrad
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 80
- Website
- polypid.com
Earnings
PYPD Q2 2025 Earnings
Period ends 2025-06-30
MetricActualYoY
Revenue——
Diluted EPS$0.78↓ -37.6%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$26.3M | -$43.1M | -$38.9M | -$22.9M | -$28.0M | -$33.0M |
| Net income | -$36.9M | -$42.6M | -$39.6M | -$23.9M | -$29.0M | -$34.2M |
| Diluted EPS | $4.48 | $68.27 | $61.09 | $16.93 | $4.91 | $2.09 |
| Operating cash flow | -$21.6M | -$32.4M | -$34.3M | -$17.2M | -$22.0M | -$27.9M |
| Free cash flow | -$22.4M | -$35.0M | -$36.1M | -$17.4M | -$22.0M | -$28.1M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — |
| Line item | Q2 '21 | Q2 '22 | Q2 '23 | Q2 '24 | Q2 '25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$10.6M | -$11.6M | -$5.8M | -$6.1M | -$9.4M |
| Net income | -$10.5M | -$11.8M | -$5.8M | -$6.3M | -$10.0M |
| Diluted EPS | $0.56 | $0.61 | $3.95 | $1.25 | $0.78 |
| Operating cash flow | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| Operating margin | — | — | — | — | — |
| Net margin | — | — | — | — | — |
Company news
Jun 1, 2026
May 13, 2026
- 67d agoPolyPid Ltd (PYPD) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challengesfinance.yahoo.com
- 68d agoPolyPid Ltd. Q1 2026 Earnings Call Summaryapp.moby.co
- 68d agoPolyPid (PYPD) Q1 2026 Earnings Transcriptfool.com
- 68d agoPolyPid Q1 Earnings Call Highlightsmarketbeat.com
- 68d agoPolyPid Q1 2026 Earnings Call: Complete Transcriptfinance.yahoo.com
- 68d agoPolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Resultsfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.